---
schema_version: "secwatch.filing_event.v1"
accession: "0000310764-25-000005"
form_type: "8-K"
ticker: "SYK"
cik: "0000310764"
company_name: "STRYKER CORP"
filed_at: "2025-01-28T23:59:59+00:00"
generated_at: "2026-05-27T08:37:32.116402+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Stryker Q4 adjusted EPS up 15.9% to $4.01, organic sales +10.2%; guides 2025 8-9% growth

## Summary
- Reported EPS fell 52.7% to $1.41 due to $818M goodwill/impairment charges on Spine; adjusted EPS rose 15.9% to $4.01.
- Organic net sales increased 10.2% in Q4 and full year 2024, driven by 9.1% volume growth and 1.1% price.
- Full-year adjusted operating margin expanded 110 bps to 25.3%; reported operating margin was 16.3%.
- 2025 guidance: organic sales growth 8-9%, adjusted EPS $13.45-$13.70; Inari acquisition expected to close late Feb with ~$590M stub sales.

## SEC filing metadata
- accession: 0000310764-25-000005
- form_type: 8-K
- ticker: SYK
- cik: 0000310764
- company_name: STRYKER CORP
- filed_at: 2025-01-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/310764/000031076425000005/0000310764-25-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/310764/000031076425000005/syk-20250128.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000310764-25-000005
- JSON: https://secwatch.observer/filing/0000310764-25-000005.json
- Plain text: https://secwatch.observer/filing/0000310764-25-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.